1:11 PM
 | 
Jan 05, 2018
 |  BC Extra  |  Company News

Takeda acquiring TiGenix for €520M

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said Friday it will acquire TiGenix N.V. (Euronext:TIG; NASDAQ:TIG) for €1.78 per share in cash, or €520 million ($617.6 million). The price is an...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >